IPO Analysis 7 min read

How to Evaluate an IPO Before Applying

Checklist for evaluating an IPO's fundamentals and valuation before applying

Index

IPO Analysis · Part 1 of 13

Rohit had the WhatsApp forward open on one screen and the IPO application form open on the other. The grey market premium quoted in the message had jumped 40% in two days, every group he was in was calling it a sure listing-day winner, and the subscription numbers were already climbing past 20x. He had about ten minutes before the day's bidding window closed. What he didn't have was a single number from the company's own balance sheet — and that, more than the GMP, is what should have decided his next move.

Practical Tips

Before applying to any IPO, check five things in this order: the company's revenue and profit trend over the last three years, whether the issue price is reasonable against listed peers, how much of the issue is an Offer for Sale versus a fresh issue, what the Risk Factors chapter of the RHP actually discloses, and only after all of that, where GMP and subscription numbers stand. If the first four don't hold up, no GMP number should change the decision.

Start With the Business, Not the GMP

Pull the company's restated financial statements from the RHP and look at three years of revenue, operating profit, and net profit — not one good quarter dressed up for the prospectus. Growth that comes from a genuine increase in customers or volumes is different from growth that comes from a one-time asset sale or a tax credit, so check what's actually driving the numbers before trusting the trend line. Watch cash flow from operations against reported profit too; a company that shows profit on paper but negative operating cash flow year after year is usually funding growth with debt or short-term window dressing, not the business itself. Tata Technologies went on to become one of the decade's standout listings largely because the underlying engineering business was genuinely profitable and growing — the market simply hadn't priced it in yet. Paytm is the inverse lesson: a weak and uncertain path to profitability was visible in the RHP well before the stock fell nearly 27% on listing day.

Check Whether the Price Actually Makes Sense

Once the business checks out, work out whether the price does. Compare the IPO's P/E and other key ratios against already-listed companies in the same sector — if the asking multiple is meaningfully higher with no clear reason (faster growth, better margins, a moat competitors don't have), that premium is a bet on hype, not fundamentals. Equally important is where the money is actually going. A fresh issue that funds expansion, debt repayment, or working capital is different from an Offer for Sale, where existing shareholders are simply cashing out and the company itself gets nothing. A heavy OFS component can signal promoters exiting rather than funding growth, which is worth asking "why now" about. This isn't a hypothetical concern: of 96 mainboard IPOs in 2025, 49 listed positively while 47 ended in losses — closer to a coin flip than retail investors tend to assume, and overpriced issues with weak fundamentals made up a large share of the losers.

Practical Tips

An Offer for Sale that makes up most of the issue size is a flag, not an automatic disqualifier — some promoters sell down for legitimate reasons like regulatory minimum public shareholding requirements. The problem is an OFS-heavy issue with no credible explanation in the RHP for why promoters are selling now, especially paired with weak revenue growth or thin margins. Read the Objects of the Issue section before applying, not after.

Read the Risk Factors Before You Read Anything Else

Every RHP has a Risk Factors chapter, and it is the most carefully lawyered, most honest part of the entire document — which is exactly why almost no retail investor reads it. This is where you'll find promoter share pledges, pending litigation, customer or supplier concentration, related-party transactions, and regulatory dependencies the company is legally required to disclose. None of this shows up in a GMP quote or a subscription chart. A company with 60% of revenue coming from two customers, or a promoter who has pledged a large chunk of their holding against personal loans, is disclosing real risk — treat it as such rather than scrolling past it to get to the financials everyone else is looking at.

Treat GMP and Subscription Numbers as Mood, Not Math

GMP and subscription data measure sentiment in the days before listing — not the value of the underlying business, and not reliably even that. Swiggy is the clearest recent case: its GMP stayed muted before listing, yet the stock went on to reward investors as the company delivered on fundamentals. The reverse happens just as often with hyped issues that list below issue price once the froth clears. The broader 2025 data backs this up: average first-day listing gains fell to roughly 8.4%, down from about 29% in 2024, as the market grew more selective about separating fundamentals from hype. There's also a behavioural pattern worth knowing: a 2024 SEBI study found 54% of allotted IPO shares are sold within a week of listing, which tells you how many applicants were chasing a quick flip rather than evaluating the business at all — and why GMP, driven heavily by that same crowd, is a sentiment gauge rather than a valuation tool.

Score It Before You Apply

A simple scorecard turns all of this into a five-minute check instead of a gut call:

FactorLooks healthy when...Flag it if...
3-year revenue & profitSteady growth, backed by real operating cash flowProfit comes from one-time items, cash flow lags earnings
Valuation vs. peersP/E broadly in line with listed comparablesMaterially higher multiple with no stated reason
Use of proceedsMostly fresh issue funding growth or debt repaymentMostly OFS, promoters exiting with no clear "why now"
RHP risk factorsSpecific, business-linked risks, clean promoter holdingVague boilerplate, heavy litigation, pledged promoter shares
GMP & subscriptionOne data point among severalThe only thing you checked

Rohit ran the hyped IPO from that WhatsApp forward through this exact grid. Margins were thin, two-thirds of the issue was an OFS with no explanation offered, and the risk factors section ran to three pages of near-identical boilerplate. He skipped it and applied instead to a quieter issue the same week — steady three-year profit growth, a mostly fresh issue, and a clean RHP. The one he skipped listed below its issue price within the month. The one he applied to listed at a modest premium and held it. Neither outcome was guaranteed going in, but only one of the two decisions was actually informed.

KEY TAKEAWAYS

Start with three years of revenue and profit, checked against real operating cash flow, not just the headline numbers. Compare the issue's valuation to already-listed peers rather than taking the price band at face value. Treat a large Offer for Sale component as a question to answer, not an automatic red flag. Read the Risk Factors chapter of the RHP before you read the GMP. Remember that GMP and subscription numbers reflect short-term sentiment, not business value — 2025's data alone showed listing-day outcomes splitting close to evenly, and roughly half of allotted shares getting flipped within a week regardless of how a company actually performed afterward. Finally, keep IPO exposure to a measured slice of your overall portfolio rather than betting heavily on any single issue, however loud the hype around it.

Category: IPO Analysis Author: Moksh Shah

Frequently Asked Questions

What's the first thing to check before applying to an IPO?
Start with the company's financials, not the grey market premium. Look at three years of revenue and profit trend in the RHP, and confirm that reported profit is backed by real operating cash flow rather than one-time gains. This tells you whether there's an actual business to own, which should come before any price or sentiment check.
Is a high GMP a good enough reason to apply to an IPO?
No. GMP reflects short-term demand among grey market participants, not the company's fundamentals or fair value. Several 2025 IPOs with modest GMP went on to perform well post-listing, while some high-GMP issues listed below their issue price. Use GMP as one data point after checking financials and valuation, never as the deciding factor.
What does a high Offer for Sale (OFS) component mean?
It means existing shareholders, often promoters, are selling their shares rather than the company raising fresh capital for growth. A large OFS isn't automatically bad, but it's worth checking the RHP for why promoters are selling now. An OFS-heavy issue paired with weak growth or thin margins deserves extra scrutiny before applying.
How do I compare an IPO's valuation to its peers?
Look up the P/E ratio (or relevant sector multiple) of already-listed companies in the same industry and compare it to the IPO's asking price. A materially higher multiple isn't automatically wrong, but the RHP or the company's growth numbers should justify it. If no clear reason is given, the extra premium is often pricing in hype rather than performance.
Where do I find an IPO's risk factors?
Every company's Red Herring Prospectus (RHP) has a dedicated Risk Factors chapter, usually near the front of the document, listing legally required disclosures such as litigation, customer concentration, and promoter share pledges. RHPs are available on the company's IPO microsite and on SEBI and stock exchange websites. It's worth reading before checking GMP or subscription numbers.
Does low subscription mean an IPO is a bad investment?
Not necessarily. Subscription reflects demand at that moment, which can be influenced by market mood, timing, or competing issues in the same window, not just the company's quality. Some soundly fundamentals-backed IPOs have been modestly subscribed and still performed well after listing. It's one signal among several, not a verdict on the business.
How much of my portfolio should go into IPOs?
There's no fixed rule, but many advisors suggest limiting overall IPO exposure to roughly 5-10% of a portfolio, applied selectively to issues that pass fundamental checks rather than every issue that's open. Treating IPOs as a small, evaluated slice of a portfolio — rather than a primary strategy — keeps a few weak picks from doing outsized damage

Notification Alerts

Notifications Disabled

Allow Notifications

Select Notification Channels
Join Telegram Alerts
100% Free (Forever)

Never Miss an IPO.

AI-Bot Driven: Lightning fast alerts.

Daily Alert Schedule

9:00 AM — IPO Calendar

Schedules for open, close, listing & allotments.

10:00 AM — Listing Updates

Live updates on IPOs listing during the day.

11:00 AM — Opening Alerts

Instant alerts for IPOs opening today.

2:00 PM — Closing Alerts

Final reminders for IPOs closing today.

REAL-TIME — Allotments & Launches

As and when out, instantly delivered.

Plus much more...
NO SPAM. NO ADS. ONLY GENUINE CONTENT.
Join Free Telegram Channel